183 related articles for article (PubMed ID: 24349361)
1. Association between the STK15 F31I polymorphism and cancer susceptibility: a meta-analysis involving 43,626 subjects.
Tang W; Qiu H; Ding H; Sun B; Wang L; Yin J; Gu H
PLoS One; 2013; 8(12):e82790. PubMed ID: 24349361
[TBL] [Abstract][Full Text] [Related]
2. STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.
Xu L; Zhou X; Jiang F; Xu L; Yin R
Cancer Epidemiol; 2014 Apr; 38(2):111-7. PubMed ID: 24252226
[TBL] [Abstract][Full Text] [Related]
3. Association between the STK15 polymorphisms and risk of cancer: a meta-analysis.
Qin J; He XF; Wei W; Liu ZZ; Xie JJ; Wang W; Du YP; Chen Y; Si HQ
Mol Genet Genomics; 2015 Feb; 290(1):97-114. PubMed ID: 25154511
[TBL] [Abstract][Full Text] [Related]
4. Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.
Tang W; Qiu H; Jiang H; Wang L; Sun B; Gu H
PLoS One; 2014; 9(3):e90328. PubMed ID: 24598702
[TBL] [Abstract][Full Text] [Related]
5. Two nonsynonymous polymorphisms (F31I and V57I) of the STK15 gene and breast cancer risk: a meta-analysis based on 5966 cases and 7609 controls.
Qin K; Wu C; Wu X
J Int Med Res; 2013 Aug; 41(4):956-63. PubMed ID: 23803310
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the STK15 F31I polymorphism and its relationship with mammographic density.
Giacomazzi J; Aguiar E; Palmero EI; Schmidt AV; Skonieski G; Duarte Filho D; Bock H; Saraiva-Pereira ML; Schuler-Faccini L; Camey SA; Caleffi M; Giugliani R; Ashton-Prolla P
Braz J Med Biol Res; 2011 Apr; 44(4):291-6. PubMed ID: 21412660
[TBL] [Abstract][Full Text] [Related]
7. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types.
Ewart-Toland A; Dai Q; Gao YT; Nagase H; Dunlop MG; Farrington SM; Barnetson RA; Anton-Culver H; Peel D; Ziogas A; Lin D; Miao X; Sun T; Ostrander EA; Stanford JL; Langlois M; Chan JM; Yuan J; Harris CC; Bowman ED; Clayman GL; Lippman SM; Lee JJ; Zheng W; Balmain A
Carcinogenesis; 2005 Aug; 26(8):1368-73. PubMed ID: 15802297
[TBL] [Abstract][Full Text] [Related]
8. Association between genetic polymorphisms in AURKA (rs2273535 and rs1047972) and breast cancer risk: a meta-analysis involving 37,221 subjects.
Dai ZJ; Kang HF; Wang XJ; Shao YP; Lin S; Zhao Y; Ren HT; Min WL; Wang M; Liu XX
Cancer Cell Int; 2014; 14(1):91. PubMed ID: 25253995
[TBL] [Abstract][Full Text] [Related]
9. Association between interferon gamma +874 T>A polymorphism and acute renal allograft rejection: evidence from published studies.
Ge YZ; Wu R; Jia RP; Liu H; Yu P; Zhao Y; Feng YM
Mol Biol Rep; 2013 Oct; 40(10):6043-51. PubMed ID: 24057242
[TBL] [Abstract][Full Text] [Related]
10. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
11. Inconsistent association between the STK15 F31I genetic polymorphism and breast cancer risk.
Fletcher O; Johnson N; Palles C; dos Santos Silva I; McCormack V; Whittaker J; Ashworth A; Peto J
J Natl Cancer Inst; 2006 Jul; 98(14):1014-8. PubMed ID: 16849685
[TBL] [Abstract][Full Text] [Related]
12. Case-control, kin-cohort and meta-analyses provide no support for STK15 F31I as a low penetrance colorectal cancer allele.
Webb EL; Rudd MF; Houlston RS
Br J Cancer; 2006 Oct; 95(8):1047-9. PubMed ID: 17003782
[TBL] [Abstract][Full Text] [Related]
13. Association between interleukin-8 rs4073 polymorphism and prostate cancer: A meta-analysis.
Chen CH; Ho CH; Hu SW; Tzou KY; Wang YH; Wu CC
J Formos Med Assoc; 2020 Jul; 119(7):1201-1210. PubMed ID: 31718853
[TBL] [Abstract][Full Text] [Related]
14. Association between transforming growth factor-beta 1 T869C polymorphism and ischemic stroke: a meta-analysis.
Peng L; Li P; Chen J; Yan K; Huo F; Han L; Li C; Tan S; Jiang X
PLoS One; 2013; 8(7):e67738. PubMed ID: 23861796
[TBL] [Abstract][Full Text] [Related]
15. The interleukin 10 -819C/T polymorphism and cancer risk: a HuGE review and meta-analysis of 73 studies including 15,942 cases and 22,336 controls.
Yu Z; Liu Q; Huang C; Wu M; Li G
OMICS; 2013 Apr; 17(4):200-14. PubMed ID: 23574339
[TBL] [Abstract][Full Text] [Related]
16. Association of fat-mass and obesity-associated gene FTO rs9939609 polymorphism with the risk of obesity among children and adolescents: a meta-analysis.
Quan LL; Wang H; Tian Y; Mu X; Zhang Y; Tao K
Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):614-23. PubMed ID: 25753879
[TBL] [Abstract][Full Text] [Related]
17. Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.
Yan Q; Chen P; Wang S; Liu N; Zhao P; Gu A
BMC Cancer; 2014 Dec; 14():950. PubMed ID: 25496056
[TBL] [Abstract][Full Text] [Related]
18. CYP1A1 MspI polymorphism is associated with prostate cancer susceptibility: evidence from a meta-analysis.
Ding G; Xu W; Liu H; Zhang M; Huang Q; Liao Z
Mol Biol Rep; 2013 May; 40(5):3483-91. PubMed ID: 23475304
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of IL-8 in 251 allele and gastric cancer susceptibility: a meta-analysis.
Wang J; Pan HF; Hu YT; Zhu Y; He Q
Dig Dis Sci; 2010 Jul; 55(7):1818-23. PubMed ID: 19777350
[TBL] [Abstract][Full Text] [Related]
20. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
Qiu LX; Wang Y; Xia ZG; Xi B; Mao C; Wang JL; Wang BY; Lv FF; Wu XH; Hu LQ
Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
